Skip to main content

2024 Impact

Greater than ever! The Lobo Cancer Challenge was celebrated at University Stadium on September 28, 2024.

1,704 Challengers in 83 teams along with 72 sponsors:
together we raised $652,000 to #UniteAgainstCancer in New Mexico!

Thank you to everyone for your contribution — Challengers, Sponsors, Volunteers, Donors — and to our community for your amazing support.

TOP FUNDRAISING AREAS:

$58,070

Leukemia, Lymphoma, Myeloma and Stem Cell Transplantation

$44,774

General Research Fund

$32,370

Adolescent and Young Adult Cancers (AYA) Research

$31,540

Women’s Cancer Research (gynecologic cancers)

$28,415

Patient Assistance Fund

$23,378

Breast Cancer Research

$17,966

Children’s Cancer Research Fund

$15,630

Polly Rogers Pancreatic Cancer Fund

$14,850

DEI Health Equity Fund

$12,525

Prostate, Renal, Bladder and Testicular Cancers Research

$12,213

Neuro-Oncology Cancers

$9,553

Lung Cancers Prevention, Research and Treatment Fund

Head & Neck Cancers Research received $5,175 and the Cancer Palliative / End of Life Care fund received $3,473. Gastrointestinal Cancer Research received $2,840; the Cancer Survivorship Clinic received $2,650; the Skin Cancer Prevention and Research Fund received $2,260; and the Early Phase Cancer Clinical Trials Program received $2,150. Training and Education of Cancer Health Professionals received $1,590 and Sarcomas and Bone Cancers Research received $350.

 

Every dollar raised by our Challengers went directly to the cancer fund of their choice at the UNM Comprehensive Cancer Center.

Learn more about each program on the Programs for Donation page. Most program descriptions include a link to their department web pages on the UNM Comprehensive Cancer Center website.

 


 

 

Connect with us


Presented By
Blake's Lotaburger logo

If you continue to use this site, you consent to use all cookies. We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy.

If you continue to use this site, you consent to use all cookies.